Karen Janice Moras, Suneel C Mundkur, Rochelle Anne Periera.
Department of Pediatrics, Kasturba Medical College, MAHE, Manipal University, Manipal, India.
Show affiliations
|
Abstract
Hepatic involvement in COVID-19 in children is typically characterized by elevation in Alanine transaminase (ALT) and Aspartate aminotransferase (AST) with preserved liver synthetic function.1 Severe hepatic involvement in COVID-19 is seen in COVID Multisystem Inflammatory Syndrome in Children (MIS-C), which typically occurs several weeks to months after the initial SARS-CoV-2 infection rather than during acute infection.(2, 3) However, there is a paucity of literature describing Paediatric cases of cholestatic jaundice as a primary manifestation of acute SARS-CoV-2 infection. We report two cases of cholestatic jaundice as the primary manifestation of COVID-19.
|